Chinook Therapeutics Inc.

KDNY | NASDAQ

Price Alert Chart Builder DCF Calculator

$40.39

+$0.09 (+0.22%)

At close: Aug 10, 2023, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

0.22%

(1Y)

Key Statistics

Market Data

Market Cap $2.71B

1D Range

40.30 40.51

52W Range

18.34 40.51

Valuation (TTM)

PE -11.61

PB 7.58

EV/EBITDA -11.05

Valuation (NTM)

Forward PE N/A

Forward PEG 0.21

Price Target $30

Cash Flow

FCF Yield -6.5%

SBC Adj. FCF Yield -7.6%

SBC Impact -15.9%

Margins

Gross Margin 71.9%

Operating Margin -4302.1%

FCF Margin -3019.3%

Growth (CAGR)

Revenue 3Y | 5Y 2.0% | -21.9%

Dil EPS 3Y | 5Y -0.9% | -45.7%

FCF 3Y | 5Y -27.7% | -44.6%

Returns

ROA -32.2%

ROE -41.2%

ROIC -35.0%

Financial Health

Net Cash

$263.18M

Current Ratio 7.59

Interest Coverage -25.78

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.